Cleared Traditional

K032994 - GM3 SERIES HV TENS, MODEL GM3X3HV (WHERE X IS PARAMETER OF DIFFERENT HOUSING)

K032994 is an FDA 510(k) clearance for GM3 SERIES HV TENS, manufactured by Gemore Technology Co, Ltd.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 82-day FDA review.

K032994 · Gemore Technology Co, Ltd. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2003
Decision
82d
Days
Class 2
Risk

K032994 is an FDA 510(k) clearance for the GM3 SERIES HV TENS, MODEL GM3X3HV (WHERE X IS PARAMETER OF DIFFERENT HOUSING). Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Gemore Technology Co, Ltd. (Tan Shui, Taipei Hsien, TW). The FDA issued a Cleared decision on December 16, 2003 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K032994

510(k) Number K032994 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 25, 2003
Decision Date December 16, 2003
Days to Decision 82 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 149d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 597
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K032994.
PREMIER PLUS
K032003 · American Imex · Jan 2004
MEDIPHYSICS PAIN TREATMENT SYSTEM, MODEL 1
K032928 · Mediphysics Pain Centers of America · Dec 2003
T-TECH DIGITAL, MODEL WL-22XXA SERIES
K033857 · Well-Life Healthcare, Inc. · Dec 2003
GEM-STIM TENS, MODELS GM3XY AND GM3AXY
K032720 · Gemore Technology Co, Ltd. · Dec 2003
BESMED VARIOUS MODELS OF TENS, BE-550/BE-660
K031374 · Besmed Health Business Corp · Nov 2003
RAINBOW GT-4A PAIN RELIEF MACHINE
K031546 · Sino-Us Information, Inc. · Nov 2003
K032994 · GM3 SERIES HV TENS, MODEL GM3X3HV (WHERE X IS PARAMETER OF DIFFERENT HOUSING)
Download PDF FDA Summary Gemore Technology Co,…